Integrating Bioinformatics and Drug Discovery: Innovations and Applications
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Bioinformatics and Systems Biology".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 74
Special Issue Editor
Interests: data-mining algorithms; systems biology; protein bioinformatics; software and database development; computational drug discovery; integrated data analysis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Integrating bioinformatics tools and molecular biology techniques can identify new drug targets, predict drug efficacy, and understand complex biological pathways. By leveraging computational methods, researchers can analyze large data sets, simulate protein–ligand interactions, optimize drug design, and accelerate the drug development process. This field of research is critical for discovering new therapeutics, providing insights into disease mechanisms at the molecular level, and paving the way for personalized medicine. Continuous innovations in bioinformatics and computational methods continue to enhance our ability to design effective drugs, reduce costs, and increase the success rate of clinical trials, making it a key research topic in modern drug discovery. This Special Issue welcomes research on the intersection of bioinformatics and drug discovery, and the transformative role that molecular biology plays in advancing drug research.
Dr. Jianwen Fang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioinformatics
- drug discovery
- target proteins
- drug therapy
- receptor–receptor interactions
- protein dynamics
- structural bioinformatics
- computational approaches
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
